| | Atherothrombosis | | | Prevent The Event: Defining The Role of Oral Antiplatelet Therapy in Atherothrombosis
Overview Atherothrombosis is the leading cause of death worldwide and the underlying process in the etiology of acute coronary syndrome (ACS), stroke and vascular death. Cardiovascular risk factors such as obesity, the metabolic syndrome, diabetes mellitus, hypertension, smoking and other "lifestyle" risks contribute to this pandemic of atherothrombotic disease. Patients with ACS, stroke/TIA and PAD (peripheral arterial disease), present major challenges to the primary care clinician in terms of managing CV risk factors and prevention of a second event. This lecture will overview current studies and treatment guidelines for PAD, ACS and Stroke and explore the role of primary care in long-term treatment of these patients.
Objectives Describe 3 clinical conditions in which dual antiplatelet therapy is recommended
Name 5 treatment recommendations for reduction of global CV risk
Faculty Kelly Anne Spratt, DO, FACC Clinical Assistant Professor of Medicine Cardiovascular Risk Intervention Program University of Pennsylvania School of Medicine Philadelphia, PA
Philip Altus, MD, MACP Professor Emeritus, Department of Medicine University of South Florida Tampa, FL
| | | Insomnia | | | Managing Insomnia in Primary Care: Understanding Current and Developing Pharmacological and Nonpharmacological Therapies
Overview Insomnia, defined as complaints of disturbed sleep in the presence of adequate opportunity and circumstance for sleep, is the most common adult sleep pathology. Besides cognition, other pathologic processes have been deleteriously associated with insomnia, including cardiovascular morbidity and glycemic control. The latest evidence about sleep pathology will be presented, including spectral analysis that indicates sleep patterns, including slow wave sleep, are important, rather than just total sleep time. Nonpharmacologic approaches, as well as current and developing pharmacotherapies used to address these sleep pathologies will be described.
Objectives Identify the underlying causes and comorbid conditions of insomnia for increased confidence in treatment
Assess the current and developing nonpharmacologic and pharmacologic approaches to the management of primary and co- morbid insomnia
Faculty David Neubauer, MD Assistant Professor, Department of Psychiatry, Johns Hopkins University School of Medicine Medical Director, Psychiatry Mobile Treatment Services, Johns Hopkins Bayview Medical Center Associate Director, Johns Hopkins Sleep Disorders Center
Paul P. Doghramji, MD, FAAFP Family Physician Collegeville Family Practice Medical Director of Health Services, Ursinus College Collegeville, PA
| | | Dyslipidemia | | | Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions
Overview This presentation will address early and aggressive LDL-C management and the clinical challenges of goal attainment. Clinicians will be provided with pathways and knowledge to help them improve their patient outcomes by goal attainment of the healthy lipid profile.
Discussion will be applicable to clinicians' practice including lifestyle changes of diet and exercise, along with pharmacologic treatment options available for lipid management in order to give the appropriate tools to get patients to their true LDL goals.
Objectives Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies
Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals
Faculty Emma Meagher, MD Associate Professor University of Pennsylvania, School of Medicine Philadelphia, PA
John Russell, MD Clinical Associate Professor of Family and Community Medicine Temple University School of Medicine Philadelphia, PA
| | | Migraine | | | Diagnosis and Effective Treatment of Migraine to Limit Allodynia and Progression to Chronic Headache
Overview This educational activity will describe and reinforce tools that enable clinicians to efficiently recognize and diagnose migraine that may have been previously undiagnosed and untreated, or who may have lapsed from treatment, and to communicate realistic treatment goals to reach the goal of improved patient outcomes.
Objectives Identify the symptoms and patterns of headache for accurate assessment of migraine, including associated risks for progression to chronic migraine, and utilize simple screening tools to overcome diagnostic challenges
Create a migraine management strategy tailored to individual patient needs that incorporates a stratified approach to pharmacological and nonpharmacological therapies and communication of realistic treatment goals to help improve patient outcomes
Faculty Frederick R. Taylor, MD, FAHS Adjunct Professor of Neurology University of Minnesota School of Medicine Director, Park Nicollet Headache Clinic and Research Center Minneapolis, MN
M. Susan Burke, MD, FACP Clinical Assistant Professor of Medicine Thomas Jefferson University Philadelphia, PA Director, Internal Medicine Clinical Care Center Lankenau Hospital Wynnewood, PA
| | | Adult Vaccines | | | Adult Immunizations: Overcoming Obstacles in Primary Care
Overview Despite the great advances in medical care represented by adult immunization, the challenges continue to be numerous and varied. This activity will explore the barriers, clarify the "myths," and provide the most updated information on adult vaccines to increase immunization rates.
Objectives Identify the Advisory Committee on Immunization Practices (ACIP) recommended adult vaccines and the recommended immunization schedules for each ACIP recommended adult vaccine
Increase knowledge and confidence regarding safety, risks, benefits, and side effects of adult immunizations and create a strategy to increase patient immunization rates, including the use of a health maintenance form or other tool for immunization review
Faculty Iyabode F. Akinsanya-Beysolow, MD, MPH Medical Officer National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Atlanta, GA
| | | Pulmonary Arterial Hypertension | | | Achieving More Ambitious Goals in Managing PAH in Primary Care
Overview Updated American College of Chest Physicians guidelines acknowledge the pace with which medical therapies for pulmonary arterial hypertension (PAH) are evolving. This educational session will address the new guidelines, diagnostic and functional assessment, and options for lifestyle and pharmacologic therapy. The discussion will be applicable to primary care practitioners and provide them with the awareness, information and evidence based therapies used to manage PAH.
Objectives Differentiate the hemodynamic abnormalities of pulmonary arterial hypertension including its etiology and pathogenesis in order to decrease morbidity and mortality of the patient population at risk
Apply clinical practice guidelines in the early detection and effective management of PAH by selecting appropriate therapeutic interventions to attain therapeutic goals for patients with PAH
Faculty Gautam Venkat Ramani, MD Assistant Professor of Medicine Director, Echocardiography Laboratory Baltimore VA Medical Center University of Maryland
Ronald A. Codario, MD, FACP Clinical Instructor in Medicine Thomas Jefferson University Hospital University of Pennsylvania Health System Philadelphia, PA
| | | Sleep Apnea | | | Obstructive Sleep Apnea: A Practitioner-Driven Educational Initiative
Overview The National Heart Lung Blood Institute (NHLBI) reports that there are 12 million Americans with obstructive sleep apnea (OSA). Despite the prevalence of this common condition, studies show that 80 -90% of people with OSA remain undiagnosed. Patients who suffer silently with undiagnosed OSA face significant quality of life and associated health issues. Identifying patients with OSA can be a challenge in the busy office setting, and requires the clinician to maintain a high level of suspicion based on sometimes subtle patient complaints, physical exam findings, and OSA risk factors. Once diagnosed and treatment is initiated, successful management is the cornerstone to better patient outcomes. As the first medical contact for most patients with OSA primary care clinicians are crucial for both recognition and management of patients with OSA. This educational activity will provide both the science and the skills that can make significant improvements in the lives of patients with OSA.
Objectives Recognize the signs and symptoms of OSA and utilize simple assessment questions to identify the possibility of OSA
Identify strategies to assess and monitor patient adherence to treatment for OSA
Faculty Karl Doghramji, MD Medical Director, Sleep Disorders Center Thomas Jefferson University Philadelphia, PA
Paul P. Doghramji, MD, FAAFP Family Physician Collegeville Family Practice Medical Director of Health Services, Ursinus College Collegeville, PA
| | | Gout | | | Front-line Management of Gout: A Step-by-Step Guide to Best Practice
Overview This program will address the key "must-know" points in gout management. The provision of case-based presentations will provide primary care clinicians with a clear step-by-step comprehension of how to manage gout and establish effective, supportive patient interaction to optimize life-long adherence to life-style and therapeutic regimens. There will be opportunities to interact with the faculty and obtain their expert opinions on clinical issues faced in managing patients with gout.
Objectives Identify that the long-term goal of gout treatment is to reduce serum urate to <6.0 mg/dL and to define the key steps in selecting and individualizing urate lowering therapy according to the disease stage; together with recognizing the importance of monitoring serum urate levels
Educate patients that an important factor in successful management includes their long-term commitment to adherence with the recommended life-style and drug interventions
Faculty M. Susan Burke, MD, FACP Clinical Assistant Professor of Medicine Thomas Jefferson University Philadelphia, PA Director, Internal Medicine Clinical Care Center Lankenau Hospital Wynnewood, PA
Naomi Schlesinger, MD Associate Professor of Medicine Chief, Division of Rheumatology University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School New Brunswick, NJ
|
|